Our Vision
Ensure innovative medicines are accessible to the right patients
Ensure patients with an unmet medical need have access to the innovative therapeutic & preventative options that they need to live better and longer lives
Secure a price for the product that reflects its true added value
Define & communicate the added value of a product based on its clinical, humanistic and economic added value, with a broad societal perspective
Work in collaboration with decision-makers to ensure the sustainability of healthcare systems
Collaborate with all relevant stakeholders to shape innovative -and sustainable- solutions for patients access to healthcare
Our Mission & Values
Our Mission is to ensure patients access to pharmaceutical & medical innovation while driving the growth of our clients’ businesses by:
- Developing future-proof market access & pricing strategies for innovative assets
- Providing excellence in commercial launch execution
- Building the client’s in-house functional expertise
Our core values are ENTREPRENEURSHIP, ACCOUNTABILITY and INTEGRITY
About iPATH Solutions™
Geoffroy "Jeff" Coteur
Founder & Chief Everything Officer
Health Investor
Jeff is a seasoned professional in the healthcare industry with 18 years of experience across market access, pricing, health economics & outcomes research, and real-world evidence strategies at Global and Regional-EU level. He has held leadership positions at pharmaceutical companies ranging from small biotech to F100 companies. Jeff has a passion for combining the science, the patients needs and the business opportunities.
Prior to founding iPATH Solutions™, Jeff was the market access leader for infectious diseases & vaccines at Janssen Pharmaceutica where he shaped the commercial strategy of early assets and business development opportunities against viral and bacterial infections.
During his tenure at Galapagos, Jeff led the market access & pricing function for the rare disease franchise in pulmonary fibrosis. He also designed the price management governance & systems in preparation of the first commercial launch of a drug for auto-immune diseases.
Jeff started his career at UCB were he shaped the market access & pricing strategy of several biologics for auto-immune and bone disorders at Global level and has launched those products across EU countries.
Our experience
Geographical experience
EU4, UK, EU-Nordics, US, Canada, Rest of EU, Japan, Australia, Brazil, China
Therapeutic area experience
Infectious diseases & vaccines, Rare diseases, Respiratory diseases, Inflammation & immunology, Rheumatology, gastroenterology, dermatology
Our services
Testimonials
With a high sense of accountability & leadership, Jeff prepared & successfully delivered a strategic presentation to senior leaders within the company
Geoffroy is a talented market access leader who is always eager to learn & grow
Geoffroy can seamlessly switch between a helicopter-level strategic view to a hands-on operational focus on access implementation
Jeff’s knowledge and expertise covers a wide range of diseases and TAs, his command of complex healthcare policy and reimbursement landscapes is deep and comprehensive
I have been impressed both by Jeff’s deep market access expertise as well as his collaboration & communication skills